Magnetic resonance imaging of pancreatic malignancy

Pancreatic malignancies continue to present a huge challenge not only to the surgeon, the gastroenterologist, and the oncologist, but to the radiologist as well. The poorly marginated, invasive nature of pancreatic ductal adenocarcinoma (PDA), the controversies regarding the clinical import of intraductal papillary mucinous neoplasms (IPMN), and the pitfalls introduced by tumor mimics are among the frustrating issues that make caring for affected patients so difficult. Dealing effectively with these tumors requires the highest possible level of imaging protocol optimization and radiologist expertise. Moreover, the patient with a pancreatic malignancy is best served when communication among imagers and clinicians flows freely, allowing for intelligent, effective patient care decisions.